Figure 1

5.5K posts

Figure 1 banner
Figure 1

Figure 1

@Figure1

Sharpen your clinical knowledge. Join 3 million HCPs using Figure 1 to share and discuss medical cases. Download the app or visit https://t.co/nKKBtk15lZ

가입일 Mart 2013
712 팔로잉13.2K 팔로워
고정된 트윗
Figure 1
Figure 1@Figure1·
With over 100,000 real patient cases and 3 million members, Figure 1 is changing the future of #MedicalEducation. Join the largest global community of medical minds and start collaborating: bit.ly/3HTa9t3
English
1
2
9
0
Figure 1
Figure 1@Figure1·
Save the date: Oncology Forum returns May 31 in Chicago After ASCO’s plenary and key data, join focused, expert‑led discussions to unpack what matters and what to do next. Step off the floor and talk it through with peers. Learn more: buff.ly/gRhXTzI #OncForum2026
Figure 1 tweet media
English
0
0
2
71
Figure 1
Figure 1@Figure1·
Introducing the Community Tab in Figure 1 🩺 ✅ Accounts to Follow ✅ Your Groups ✅ Interactive Case Labs Debates ✅ Public Groups ✅ Expert Feeds from real doctors Update the app & check it out. #MedTwitter #MedEd #ClinicalLearning #PatientCare
Figure 1 tweet media
English
0
0
1
133
Figure 1
Figure 1@Figure1·
Recent FDA rejections of several therapies for rare diseases have drawn criticism that argues that regulatory expectations may be becoming more difficult to meet. Is the current regulatory framework well-suited for rare disease drug development? Let us know. #RareDisease #FDA
Figure 1 tweet media
English
0
0
0
169
Figure 1
Figure 1@Figure1·
A painful, pruritic red plaque with erosions on the lower leg. What's your next move? Create a treatment plan for this patient and see how it compares to the real case. Take the challenge on the Figure 1 app: buff.ly/7jijVdE #MedEd #VenousStasis #VascularMedicine
Figure 1 tweet media
English
0
0
1
172
Figure 1
Figure 1@Figure1·
Is it time for rheumatologists to prescribe GLP1’s? New data hints at better disease control in rheumatic conditions, and @ebrheum discusses whether it's time for rheumatologists to start prescribing them. Read here: buff.ly/FblQUJ4 #Rheumatology #GLP1 #MedTwitter
Figure 1 tweet media
English
0
2
5
568
Figure 1
Figure 1@Figure1·
Introducing Case Labs. Our first case explores treatment decision-making in BRCA2-mutated metastatic hormone-sensitive prostate cancer, led by @BGarmezy and @mkbupathi of @OncologyDecoded Join the debate and engage with experts for the next 30 days: buff.ly/VVzFxKt
Figure 1 tweet media
English
1
3
2
174
Figure 1
Figure 1@Figure1·
The final @Uromigos Year in Review episode is live — recapping 2025 bladder cancer advances, from ADCs and EV+pembro to CTDNA in risk assessment & treatment response. Listen now: buff.ly/5rFKCuA
Figure 1 tweet media
English
0
0
0
311
Figure 1
Figure 1@Figure1·
Episode 2 of the @Uromigos Year in Review series is live. Reviewing prostate cancer developments from 2025, focusing on personalized therapy in the mHSPC setting, including PARP inhibitors, radioligands, AKT inhibitors, and ARPI use in high-risk disease. guoncologynow.com/podcast/episod…
English
0
0
1
328
Figure 1
Figure 1@Figure1·
Our friends @Uromigos have a Year in Review podcast series on key renal oncology updates from 2025. Episode 1 covers RCC highlights, clinical debates, and what's coming next. Listen now: guoncologynow.com/podcast/episod…
English
0
0
0
287

탐색

@FeedSpot @EBRheum @BGarmezy @mkbupathi @OncologyDecoded @AmitGoyalMD @CardioNerds @Uromigos